+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Vascular access thrombosis is not related to presence of antiphospholipid antibodies in patients on chronic hemodialysis



Vascular access thrombosis is not related to presence of antiphospholipid antibodies in patients on chronic hemodialysis



Nephron 92(4): 957-958




(PDF emailed within 1 workday: $29.90)

Accession: 036031405

Download citation: RISBibTeXText

PMID: 12399653


Related references

Vascular Access Thrombosis Is Not Related to Presence of Antiphospholipid Antibodies in Patients on Chronic Hemodialysis. Nephron 92(4): 957-958, 2002

Antiphospholipid antibodies and hemodialysis vascular access thrombosis. Nephrology Nursing Journal 28(3): 346-347, 2002

Preliminary analysis of the prevalence of anti-heparin antibodies in hemodialysis patients with vascular access related thrombosis. Blood 98(11 Part 2): 100b-101b, November 16, 2001

IgM anticardiolipin antibodies are associated with stenosis of vascular access in hemodialysis patients but do not predict thrombosis. Clinical Nephrology 56(6): 428-434, 2002

IgM-anticardiolipin antibody and vascular access thrombosis in chronic hemodialysis patients. Renal Failure 27(1): 25-30, 2005

Role of thrombophilia in vascular access thrombosis among chronic hemodialysis patients in Tunisia. Therapeutic Apheresis and Dialysis 15(1): 40-43, 2011

Atrial fibrillation linked to vascular access thrombosis in chronic hemodialysis patients. Journal of Atherosclerosis and Thrombosis 18(6): 448-453, 2011

Frequency of anti-heparin-platelet factor 4 antibodies in hemodialysis patients and correlation with recurrent vascular access thrombosis. American Journal of Hematology 69(1): 72-73, 2002

Hyperhomocysteinaemia and vascular access thrombosis among chronic hemodialysis patients in Taiwan: a retrospective study. International Journal of Clinical Practice 60(12): 1596-1599, 2006

Use of enoxaparin to diminish the incidence of vascular access stenosis/thrombosis in chronic hemodialysis patients. International Urology and Nephrology 43(2): 499-505, 2011

Thrombosis of vascular access associated with factor V Leiden, antiphospholipid antibodies and antiheparin antibodies in a young woman on dialysis receiving warfarin following mitral valve replacement. Nephrology, Dialysis, Transplantation 21(6): 1719-1720, 2006

The prevalence of antibodies to the platelet factor 4 -heparin complex and association with access thrombosis in patients on chronic hemodialysis. Thrombosis Research 120(2): 215-220, 2006

Recombinant streptokinase treatment of thrombosis of the permanent vascular access in chronic renal insufficiency patients treated with periodic hemodialysis. Biotecnologia Aplicada 12(3): 195-196, 1995

The presence of anti-phosphatidylserine antibodies in patients with autoimmune diseases with no other antiphospholipid antibodies is not associated with thrombosis. Journal of Autoimmunity 15(2): A60, Sept, 2000

Anticardiolipin antibodies and vascular access thrombosis in Taiwanese haemodialysis patients with chronic hepatitis C: a retrospective study. International Journal of Clinical Practice 60(12): 1591-1595, 2006